Abstract:Background: Traumatic brain injury (TBI) is a major cause of morbidity and mortality, affecting millions annually worldwide. Although the majority of TBI patients return to premorbid baseline, a subset of patient can develop persistent and often debilitating neurocognitive and behavioral changes. The etiology of TBI within the clinical setting is inherently heterogenous, ranging from sport related injuries, fall related injuries and motor vehicle accidents in the civilian setting, to blast injuries in the military setting. Objective: Animal models of TBI, offer the distinct advantage of controlling for injury modality, duration and severity. Furthermore, preclinical models of TBI have provided the necessary temporal opportunity to study the chronic neuropathological sequelae of TBI, including neurodegenerative sequelae such as tauopathy and neuroinflammation within the finite experimental timeline. Despite the high prevalence of TBI, there are currently no disease modifying regimen for TBI, and the current clinical treatments remain largely symptom based. The preclinical models have provided the necessary biological substrate to examine the disease modifying effect of various pharmacological agents and have imperative translational value. Methods: The current review will include a comprehensive survey of well-established preclinical models, including classic preclinical models including weight drop, blast injury, fluid percussion injury, controlled cortical impact injury, as well as more novel injury models including closed-head impact model of engineered rotational acceleration (CHIMERA) models and closed-head projectile concussive impact model (PCI). In addition to rodent preclinical models, the review will include an overview of other species including large animal models and Drosophila . Results: There are major neuropathological perturbations post TBI captured in various preclinical models, which include neuroinflammation, calcium dysregulation, tauopathy, mitochondrial dysfunction and oxidative stress, axonopathy, as well as glymphatic system disruption. Conclusion: The preclinical models of TBI continue to offer valuable translational insight, as well as essential neurobiological basis to examine specific disease modifying therapeutic regimen.

A Systematic Review of Traumatic Brain Injury in Modern Rodent Models: Current Status and Future Prospects

In Vitro Models of Traumatic Brain Injury: A Systematic Review

An overview of preclinical models of traumatic brain injury (TBI): relevance to pathophysiological mechanisms

Animal models of traumatic brain injury: a review of pathophysiology to biomarkers and treatments

Models of traumatic brain injury-highlights and drawbacks

Animal Models of Traumatic Brain Injury and Assessment of Injury Severity

The Potential of Stem Cells in Treatment of Traumatic Brain Injury

A strike to the head: Parallels between the pediatric and adult human and the rodent in traumatic brain injury

'Comprehensive review of emerging drug targets in traumatic brain injury (TBI): challenges and future scope

Traumatic brain injury: Symptoms to systems in the 21st century

Traumatic Brain Injury: a Review of Characteristics, Molecular Basis and Management.

A novel simple traumatic brain injury mouse model

Comparison to an Established Magnetic Resonance Imaging Technique

The recent two decades of traumatic brain injury: a bibliometric analysis and systematic review

Progress to date using large mammal animal models of traumatic brain injury

Prospects for Nerve Regeneration and Gene Therapy in the Treatment of Traumatic Brain Injury

[Advance in Animal Models of Traumatic Brain Injury].

[Injury mechanism, clinical status and prospects of traumatic brain injury]

Advances in Neurorehabilitation: Strategies and Outcomes for Traumatic Brain Injury Recovery

Optimization of a translational murine model of closed-head traumatic brain injury

Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?